Utilizing Pulsed Electromagnetic Field (PEMF) Therapy (Diapulse®) for Drug-Free Pain Management to Eliminate Reliance on Opioids for Non-Malignant Chronic Pain: A literature Review and Proposal for Pilot Study
Article Sidebar
Main Article Content
Abstract
The Federal and State governments have declared the presence of an opioid addiction pandemic in the United States claiming the lives of more than 55,000 in 2015 (Rudd RA, Seth P, David F and Scholl L. 2016). The pharmaceutical manufacturers of the numerous FDA-approved opioid drugs are raking in more than $5 billion per year with about 2 million chronic pain sufferers addicted. The irony of this narcotic use and abuse conundrum is the existence of evidence-based technology for drug-free pain management which is not covered for reimbursement among public and private third-party payers. Therefore, this paper is presented to propose a pilot study to demonstrate the efficacy of resolving the chronic inflammation, edema and ischemia that causes non-malignant chronic pain with PEMF therapy, a non-invasive, non-thermal radio transmission of electrical impulses, thereby invalidating the legitimacy of prescribing opioid analgesics in such cases.
Article Details
Copyright (c) 2017 Sharon TA.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Lyapustina T, Alexander CG. The prescription opioid addiction and abuse epidemic: how it happened and what we can do about it. The Pharmaceutical Journal. 2015; 11: 1-9. Ref.: http://bit.ly/2X7YzFv
Van Zee A. The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy. Am J Public Health. 2009; 99: 221-227. Ref.: http://bit.ly/2XFXWjn
Rudd RA, Seth P, David F, Scholl L. Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015. Morbidity and Mortality Weekly Report US Department of Health and Human Services/Centers for Disease Control and Prevention. 2016; 65: 1445-1452. Ref.: http://bit.ly/2XbCypc
Gostin LO, Hodge JG, Noe SA. Reframing the Opioid Epidemic as a National Emergency. JAMA. 2007; 318: 1539-1540. Ref.: http://bit.ly/2KjaHxo
Harper WL, Schmidt WK, Kubat NJ, Isenberg RA. An open-label pilot study of pulsed electromagnetic field therapy inthe treatment of failed back surgery syndrome pain. Int Med Case Rep J. 2015; 8: 13-22. Ref.: http://bit.ly/2RfxJ8L
Reddy RS. Effect of pulsed electromagnetic field therapy on pain, pressure pain threshold, and pain-free grip strength in participants with lateral epicondylitis. Saudi J Sports Med. 2017; 7: 93-96. Ref.: http://bit.ly/2wVa30g
Rohde CH, Taylor EM, Alonso A, Ascherman JA, Hardy KL. et al. Pulsed Electromagnetic Fields Reduce Postoperative Interleukin – 1β, Pain, and Inflammation: A Double-Blind, Placebo-Controlled Study in TRAM Flap Breast Reconstruction Patients. Plast Reconstr Surg. 2015; 135: 808e-817e. Ref.: http://bit.ly/2Zn8rsd
Graak V, Chaudhary S, Bal BS, Sandhu JS. Evaluation of the efficacy of pulsed electromagnetic field in the management of patients with diabetic polyneuropathy. Int J Diabetes Dev Ctries. 2009; 29: 56-61. Ref.: http://bit.ly/2Xcs1tH
Bagnato GL, Miceli G, Marino N, Sciortino D, Bagnato GF. Pulsed electromagnetic fields in knee osteoarthritis: adouble blind, placebo-controlled, randomized clinicaltrial. Rheumatology. Rheumatology (Oxford) 2015; 55: 755-762. Ref.: http://bit.ly/2Fbmj17
Sharon TA. An Investigation of the Effects of Pulsed Electromagnetic Field Therapy on Plantar Skin Blood Perfusion in People with Diabetes Mellitus Type 2: A Pilot Study. 2015; 3732465. Ref.: http://bit.ly/2WHVmx1
Schneiderhan J, Clauw D, Schwenk TL. Primary Care of Patients with Chronic Pain. JAMA. 2017; 317: 2367-2368. Ref.: http://bit.ly/2IfsrHF